Covered recipient · General Payments record
JAMES ROBERT BAILEY
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$2,720.93
- Reported across 162 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $506.29 | 32 |
| Education | $23.70 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $238.39 | 19 |
| Janssen Biotech, Inc. | $70.83 | 3 |
| Ardelyx, Inc. | $51.16 | 2 |
| GENZYME CORPORATION | $36.32 | 2 |
| Regeneron Healthcare Solutions, Inc. | $34.11 | 2 |
| Celgene Corporation | $25.30 | 1 |
| Celltrion USA Inc. | $23.70 | 1 |
| Phathom Pharmaceuticals, Inc. | $21.76 | 1 |
| Ipsen Biopharmaceuticals, Inc | $14.86 | 1 |
| Madrigal Pharmaceuticals | $13.56 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.09 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103265005 | CMS |
| ABBVIE INC. | $9.31 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103265007 | CMS |
| ABBVIE INC. | $12.35 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103265009 | CMS |
| ABBVIE INC. | $5.00 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103265011 | CMS |
| ABBVIE INC. | $9.20 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103265013 | CMS |
| ABBVIE INC. | $15.72 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103265015 | CMS |
| ABBVIE INC. | $9.61 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103265017 | CMS |
| ABBVIE INC. | $14.00 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103265019 | CMS |
| ABBVIE INC. | $5.10 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103265021 | CMS |
| ABBVIE INC. | $17.32 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103265023 | CMS |
| ABBVIE INC. | $18.95 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103265025 | CMS |
| ABBVIE INC. | $25.43 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103265027 | CMS |
| ABBVIE INC. | $5.00 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103265029 | CMS |
| ABBVIE INC. | $5.25 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103265031 | CMS |
| ABBVIE INC. | $2.78 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103265033 | CMS |
| ABBVIE INC. | $15.87 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103265035 | CMS |
| ABBVIE INC. | $5.14 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103265037 | CMS |
| ABBVIE INC. | $21.00 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103265039 | CMS |
| ABBVIE INC. | $26.27 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103265041 | CMS |
| Ardelyx, Inc. | $30.91 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146670170 | CMS |
| Ardelyx, Inc. | $20.25 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146670172 | CMS |
| Celgene Corporation | $25.30 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101149147 | CMS |
| Celltrion USA Inc. | $23.70 | 05/06/2024 | Education | Undisputed | 01/23/2026 | 1075848563 | CMS |
| GENZYME CORPORATION | $15.72 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139864454 | CMS |
| GENZYME CORPORATION | $20.60 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139864460 | CMS |
| Ipsen Biopharmaceuticals, Inc | $14.86 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091980145 | CMS |
| Janssen Biotech, Inc. | $25.61 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078620960 | CMS |
| Janssen Biotech, Inc. | $21.65 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078623062 | CMS |
| Janssen Biotech, Inc. | $23.57 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078621890 | CMS |
| Madrigal Pharmaceuticals | $13.56 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144161047 | CMS |
| Phathom Pharmaceuticals, Inc. | $21.76 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151037627 | CMS |
| Regeneron Healthcare Solutions, Inc. | $20.13 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114003591 | CMS |
| Regeneron Healthcare Solutions, Inc. | $13.98 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114003593 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.